INSIGHTS ON CELL & GENE THERAPY LOGISTICS
-
![tablet for medicine management, stock research or inventory, Digital technology-GettyImages-1666055403]( "Reducing Inventory Errors In Clinical Trials")
Reducing Inventory Errors In Clinical TrialsCan a digital double-check save your trial from data errors? How does verifying shipments at receipt slash inventory mistakes? Learn to protect protocol integrity and patient safety.
-
![clinical-trials-regulation-GettyImages-2211671788]( "9 Logistics And Distribution Recommendations For CGTs")
9 Logistics And Distribution Recommendations For CGTsCell and gene therapy commercialization requires tailored logistics strategies. Explore nine recommendations covering site readiness, reimbursement gaps, packaging, testing, and coordination.
-
![cancer cell screening, disease treatment medical-GettyImages-2176920684]( "Inside March Biosciences' CD5-Targeting CAR-T Approach")
Inside March Biosciences' CD5-Targeting CAR-T ApproachFratricide is one of the key reasons T-cell therapies targeting T-cell malignancies have faltered. March's approach aims to solve that with its MB-105 candidate.
-
![Cryoport]( "Accelerate Your Trials With An End‑To‑End Supply Chain Model")
Accelerate Your Trials With An End‑To‑End Supply Chain ModelAn end-to-end supply chain model helps clinical trials move faster while maintaining visibility, control, and risk management across complex, temperature‑sensitive, and global operations.
-
![clinical-trial-supply-challenges-GettyImages-2161372208]( "From Bench To Breakthrough: How Custom Kitting Fuels Precision Trials")
From Bench To Breakthrough: How Custom Kitting Fuels Precision TrialsReduce trial variability and ensure protocol compliance with standardized custom kitting that transforms complex sample collection into a streamlined, strategic advantage for clinical success.
-
![Closed road-GettyImages-648768936]( "How AI Could Clear Logistics Roadblocks Limiting Patient Access To CGT")
How AI Could Clear Logistics Roadblocks Limiting Patient Access To CGTPatient access often gets mischaracterized solely as a cost and pricing issue. A discussion among industry leaders reaches a deeper, more complex conclusion.
-
![GettyImages-1293773576-lab-team-collaboration-planning-research]( "When CGT Supply Chains Break Down: 5 Operational Gaps That Put Patient Outcomes At Risk")
When CGT Supply Chains Break Down: 5 Operational Gaps That Put Patient Outcomes At RiskExamine five of the most consequential gaps in CGT supply chain performance and learn what high-functioning teams do differently to protect patient outcomes before a failure occurs.
-
![GettyImages-2206787488]( "Mapping Candel Therapeutics' Sprint To The BLA Finish Line")
Mapping Candel Therapeutics' Sprint To The BLA Finish LineLeaders from the adenovirus/prodrug developer discuss the complex balancing act of preparing to scale up for commercial manufacturing without overextension.
-
![test tubes, dropper, glass vials, pharmaceutical innovation-GettyImages-2157720330]( "Move Beyond LAL")
Move Beyond LALUncover how how switching from LAL to rFC can enhance sustainability, improve testing reliability, and strengthen supply-chain resilience in endotoxin testing.
-
![Merck Building-shmear]( "Biopharma Supply, Reimagined: Regional, Resilient Manufacturing")
Biopharma Supply, Reimagined: Regional, Resilient ManufacturingPersistent disruption is redefining biopharma supply chains. Explore how regional manufacturing, integrated risk management, and closer collaboration help build resilience and improve agility.
